Abstract
Purpose:
Reliable self-assessment of a patients’ visual function can improve early detection of worsening macular function. mVT provides patients with a handheld, electronic platform to assess visual function based on shape discrimination.
Methods:
Case series comparing mVT self-assessments to patients’ snellen acuity, central macular thickness and clinical course during treatment for maculopathy.
Results:
36 patients were monitored for 180-550 days during treatment of diabetic maculopathy (29) and age-related maculopathy (7). Self-monitoring correlated well with the patients’ snellen visual acuity and OCT measured central macular thickness.
Conclusions:
mVT provided a reliable self-measure of visual function in patients with macular edema.
Keywords: 754 visual acuity •
412 age-related macular degeneration •
499 diabetic retinopathy